Shroom Progress! MindMed Advances Towards a Phase 2 LSD Microdosing Trial For Adult ADHD
Aftermarket MindMed (NEO:MMED) announced they entered into a clinical trial agreement with Maastricht University to undertake a Phase 2a clinical trial for
Read more